Furthermore, we also confirmed CD47 overexpression in all tumor cell lines (U251vIII: 56.5%, U251: 51.4%, U87: 53.5%, BS153: 80.6% and Raji: 58.4%), compared to NSCs used as a normal brain cell control (Supplementary Fig. 2a, right plot). This evidence concerns the gene CD47 and neoplasm.